Warner Financial Inc. Boosts Stock Position in Johnson & Johnson (NYSE:JNJ)

Warner Financial Inc. raised its position in Johnson & Johnson (NYSE:JNJ) by 1.6% during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 5,583 shares of the company’s stock after purchasing an additional 86 shares during the period. Warner Financial Inc.’s holdings in Johnson & Johnson were worth $926,000 at the end of the most recent reporting period.

Other hedge funds also recently modified their holdings of the company. Kingswood Wealth Advisors LLC lifted its stake in shares of Johnson & Johnson by 112.3% during the 1st quarter. Kingswood Wealth Advisors LLC now owns 30,037 shares of the company’s stock worth $4,739,000 after purchasing an additional 15,887 shares during the period. Accelerate Investment Advisors LLC grew its position in shares of Johnson & Johnson by 12.6% in the first quarter. Accelerate Investment Advisors LLC now owns 2,007 shares of the company’s stock valued at $333,000 after purchasing an additional 224 shares during the period. Hoge Financial Services LLC acquired a new position in Johnson & Johnson in the first quarter valued at $215,000. Wells Trecaso Financial Group LLC lifted its position in Johnson & Johnson by 2.4% during the first quarter. Wells Trecaso Financial Group LLC now owns 52,711 shares of the company’s stock worth $8,741,000 after buying an additional 1,259 shares during the period. Finally, Wolf Group Capital Advisors boosted its stake in Johnson & Johnson by 8.5% in the 1st quarter. Wolf Group Capital Advisors now owns 15,766 shares of the company’s stock worth $2,615,000 after buying an additional 1,235 shares during the last quarter. 69.55% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several brokerages have recently weighed in on JNJ. Raymond James Financial cut their price objective on shares of Johnson & Johnson from $165.00 to $162.00 and set an “outperform” rating on the stock in a report on Monday, April 14th. Sanford C. Bernstein reaffirmed a “market perform” rating on shares of Johnson & Johnson in a research note on Wednesday, April 16th. Royal Bank Of Canada reissued an “outperform” rating and set a $181.00 price objective on shares of Johnson & Johnson in a research note on Thursday, June 5th. The Goldman Sachs Group raised Johnson & Johnson from a “neutral” rating to a “buy” rating and increased their target price for the stock from $157.00 to $172.00 in a research report on Wednesday, April 9th. Finally, Barclays reduced their target price on Johnson & Johnson from $166.00 to $165.00 and set an “equal weight” rating on the stock in a report on Thursday, April 17th. Eleven equities research analysts have rated the stock with a hold rating, eight have given a buy rating and two have assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, Johnson & Johnson presently has an average rating of “Moderate Buy” and a consensus price target of $170.88.

Johnson & Johnson Trading Down 1.1%

JNJ opened at $150.77 on Thursday. The firm’s 50 day moving average is $154.06 and its 200-day moving average is $153.67. Johnson & Johnson has a 52-week low of $140.68 and a 52-week high of $169.99. The company has a quick ratio of 1.03, a current ratio of 1.26 and a debt-to-equity ratio of 0.49. The firm has a market capitalization of $362.76 billion, a P/E ratio of 16.77, a P/E/G ratio of 2.31 and a beta of 0.42.

Johnson & Johnson (NYSE:JNJ) last released its quarterly earnings results on Tuesday, April 15th. The company reported $2.77 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.59 by $0.18. The firm had revenue of $21.89 billion for the quarter, compared to the consensus estimate of $21.65 billion. Johnson & Johnson had a net margin of 24.42% and a return on equity of 33.46%. Analysts expect that Johnson & Johnson will post 10.58 EPS for the current fiscal year.

Johnson & Johnson Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, June 10th. Shareholders of record on Tuesday, May 27th were paid a dividend of $1.30 per share. This represents a $5.20 dividend on an annualized basis and a yield of 3.45%. The ex-dividend date of this dividend was Tuesday, May 27th. This is a positive change from Johnson & Johnson’s previous quarterly dividend of $1.24. Johnson & Johnson’s dividend payout ratio (DPR) is 57.84%.

Johnson & Johnson Profile

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension.